Waldenström makroglobulinemili bir hastada mandibuler inatçı enfeksiyon olgusu

Waldenström makroglobulinemili bir hastada mandibuler inatçı enfeksiyon olgusu

Waldenström Makroglobulinemisi WM , farklılaşmış terminal B lenfositlerin neoplastik klonal proliferasyonuyla, aşırı IgM üretimiyle karakterize nadir görülen bir hastalıktır. Bu hastalık, monoklonal IgM proteiniyle karakterize lenfoplasmositik lenfomadır. Osteomiyelit ise; bir mikroorganizmanın inf...

Full description

Bibliographic Details
Main Authors:	Şakir Katı, Cahit Üçok, Muhit Özcan, Selami Toprak
Format:	Article
Language:	English
Published:	Ankara University 2012-05-01
Series:	European Annals of Dental Sciences
Subjects:	waldenström macroglobulinemia stubborness infection. sözcükler: waldenström makroglobulinemisi ønatçõ enfeksiyon.
Online Access:	https://dergipark.org.tr/en/download/article-file/1866036

Similar Items

Splenic re-irradiation for waldenstrőm’s macroglobulinemia
by: Wei Zhou, et al.
Published: (2012-04-01)

Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
by: Nurhilal Büyükkurt, et al.
Published: (2023-06-01)

Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
by: Xiaowei Xu, et al.
Published: (2013-12-01)

Increased glutathione utilization augments tumor cell proliferation in Waldenstrom Macroglobulinemia
by: Shahrzad Jalali, et al.
Published: (2020-09-01)

Macroglobulinemia de Waldenström con transformación a Linfoma del manto
by: M. Martínez Gabarrón, et al.
Published: (2013-06-01)

Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström’s macroglobulinemia
by: Omar Abdulfattah, et al.
Published: (2018-03-01)

Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
by: Kratochvil David, et al.
Published: (2012-12-01)

Macroglobulinemia de Waldenström - remissão completa após tratamento com rituximabe Successful outcome in Waldenström's macroglobulinemia treated with rituximab
by: Flavia C. F. Pimenta, et al.
Published: (2008-10-01)

Severe nephritis as initial sign of Waldenström’s macroglobulinemia
by: Thomas Knoop, et al.
Published: (2019-12-01)

Monoclonal antibody-based therapies for Waldenström's macroglobulinemia
by: Despina Fotiou, et al.
Published: (2022-01-01)

Cutaneous amyloidosis as the first presentation of Waldenstrom macroglobulinemia
by: Rana Rafiei, et al.
Published: (2020-05-01)

Ventricular Tachycardia Storm in a Patient Treated With Ibrutinib for Waldenstrom Macroglobulinemia
by: Anantha Sriharsha Madgula, MBBS, et al.
Published: (2020-09-01)

A rare clinical presentation of Waldenström Macroglobulinemia mimicking lung cancer
by: Michael RT. Laursen, et al.
Published: (2022-01-01)

WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
by: Maddalena Mazzucchelli, et al.
Published: (2018-01-01)

A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
by: Wanlu Ma, et al.
Published: (2021-02-01)

Clinicopathological profile of Waldenström's macroglobulinemia: Experience from a tertiary care center
by: Gautam Kumar Vasnik, et al.
Published: (2020-01-01)

A 44-Year-Old Man with Waldenstrom Macroglobulinemia and Bilateral Maxillary Sinusitis
by: Shinta Oktya Wardhani, et al.
Published: (2016-11-01)

Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
by: Jang Ho Cho, et al.
Published: (2021-05-01)

Cutaneous macroglobulinosis with Waldenström macroglobulinemia
by: Hussein M.M. Hassab-El-Naby, MD, et al.
Published: (2020-08-01)

Zanubrutinib in patients with treatment‐naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded‐access study of 50 patients in the United States
by: Jorge J Castillo, et al.
Published: (2023-02-01)

Mixed cryoglobulinemia; a rare presentation of Waldenström macroglobulinemia
by: Catarina Isabel Ribeiro, et al.
Published: (2022-07-01)

Waldenstrom's macroglobulinemia: An unusual cause of nonhealing leg ulcers
by: Navjyot Kaur, et al.
Published: (2017-01-01)

A rare case report of waldenström macroglobulinemia converted to serum low IgM
by: Yuan Xiang, et al.
Published: (2023-01-01)

Acute cryoglobulinemic vasculitis following rituximab infusion for waldenström macroglobulinemia
by: Zach Thornton, BA, et al.
Published: (2023-05-01)

Mast cell density and its clinical relevance in Waldenström's macroglobulinemia
by: Richard Lemal, et al.
Published: (2022-05-01)

A pilot study on dasatinib in patients with Waldenström macroglobulinemia progressing on ibrutinib
by: Jorge J. Castillo, et al.
Published: (2022-08-01)

Diagnóstico presuntivo de la macroglobulinemia de Waldenström Presumptive diagnosis of the macroglobulinemia of Waldenström
by: Ana Dolores Izquierdo Calzado
Published: (2012-04-01)

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
by: Abdulkadir Erçalışkan, et al.
Published: (2022-11-01)

Waldenstroms Macroglobulinemia Patient Presenting with Rare ‘lytic’ Lesions and Hypercalcemia: A Diagnostic Dilemma
by: Khalid Mehmood, et al.
Published: (2014-11-01)

Waldenstrom's Macroglobulinemia: A case report
by: Nejima Kolikkat, et al.
Published: (2020-01-01)

Monoclonal immunoglobulin as a prognostic factor for the severity of bone damage in paraproteinemic hemoblastoses and Waldenström’s macroglobulinemia
by: O. N. Pisarevskaya, et al.
Published: (2024-01-01)

Incidence, prevalence, mortality, and causes of death in Waldenström macroglobulinemia: a nationwide, population-based cohort study
by: Seri Jeong, et al.
Published: (2020-07-01)

Idelalisib in a patient with refractory Waldenström’s macroglobulinemia complicated by anuric renal failure: a case report
by: M. D’Aveni-Piney, et al.
Published: (2018-06-01)

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
by: Rayan Kaedbey, et al.
Published: (2022-09-01)

Macroglobulinemia de Waldenström com hemorragia intra-ocular Waldenström's macroglobulinaemia with intraocular hemorrhage
by: João J. Nassaralla Júnior, et al.
Published: (2006-12-01)

Nephrotic Syndrome and Waldenstrom’s Macroglobulinemia: A Case Report
by: Ana Isabel Oliveira, et al.
Published: (2023-06-01)

Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy
by: Andrea Aiello, et al.
Published: (2017-01-01)

Waldenström's macroglobulinemia with necrotic extremities: A case with challenging diagnosis
by: Seyyed Mojtaba Nekooghadam, et al.
Published: (2023-09-01)

THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA
by: Francesca Ricci, et al.
Published: (2011-07-01)

Extramedullary disease in Waldenström macroglobulinemia: A population‐based observational study
by: Simon Østergaard, et al.
Published: (2024-12-01)